Aclaris Therapeutics Inc (ACRS)
EBITDA Margin
-1313.57%
Quarterly · Period ending:
ACRS EBITDA Margin
Latest reported-1313.57%period ending
Latest reported-1313.57%period ending
ACRS Quarterly EBITDA Margin (0.00% → -1313.57%)
Quarterly ebitda margin
High-resolution chart · PNG
ACRS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -1,313.5666% | |
| -988.0762% | |
| -1,520.695% | |
| -439.6484% | |
| -945.076% | |
| -1,213.4708% | |
| -151.1997% | |
| -218.4077% | |
| -448.7346% | |
| -662.5521% | |
| -134.2629% | |
| -316.365% | |
| -1,716.2119% | |
| -1,207.2785% | |
| -281.0396% | |
| -97.1764% | |
| -1,582.9843% | |
| -1,369.5114% | |
| -1,365.4897% | |
| -1,157.5648% | |
| -710.4715% | |
| -664.1531% | |
| -858.2278% | |
| -638.2333% | |
| -526.6373% | |
| -935.5366% | |
| -1,589.4977% | |
| -2,159.9186% | |
| -378.8576% | |
| -492.4618% | |
| -1,024.6116% | |
| -1,297.1744% | |
| -840.6692% | |
| -2,768.1574% | |
| -2,501.001% | |
| -2,725.1462% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |